Low serum deoxyribonuclease I activity is associated with antiTNF-alpha induced skin adverse events in patients with inflammatory bowel disease
Original articleGastroent Hepatol 2012; 66(1): 23-31.
Summarypdf Karin Malíčková, Dana Ďuricová, Martin Bortlík, Viktor Komárek, Naděžda Machková, Arnošt Komárek, Ivana Janatková, Milan LukášSerum zymogen glycoprotein 2 antibodies (anti-GP2) in patients with inflammatory bowel disease
Original articleGastroent Hepatol 2013; 67(1): 10-16.
Summarypdf Karin Malíčková, Dana Ďuricová, Martin Bortlík, Luděk Hrdlička, Naděžda Machková, Milan LukášFecal calgranulin C in patients with inflammatory bowel disease
Original articleGastroent Hepatol 2014; 68(1): 10-13.
Summarypdf Karin Malíčková, Martin Bortlík, Dana Ďuricová, Martin Lukáš, Luděk Hrdlička, Naděžda Machková, Milan LukášThe report about nationwide interlaboratory comparisons of the examination of faecal calprotectin
Congress reportGastroent Hepatol 2014; 68(6): 532–534. doi:10.14735/amgh2014532
pdf Karin MalíčkováImmunopatological complications of anti-TNF-α biological treatment
Review articleGastroent Hepatol 2016; 70(1): 45–50. doi:10.14735/amgh2016csgh.info02
SummaryLiteraturepdf Karin MalíčkováBiosimilar infliximab in anti-TNF-naïve IBD patients – 1-year clinical follow-up
Original articleGastroent Hepatol 2016; 70(6): 514–522. doi:10.14735/amgh2016514
SummaryLiteraturepdf Martin Kolář, Dana Ďuricová, Martin Bortlík, Veronika Hrubá, Naděžda Machková, Katarína Mitrová, Karin Malíčková, Martin Lukáš, Milan LukášPregnancy outcomes in women with inflammatory bowel disease treated with biosimilar infliximab
Original articleGastroent Hepatol 2018; 72(1): 20–26. doi:10.14735/amgh201820
SummaryLiteraturepdf Martin Kolář, Martin Bortlík, Dana Ďuricová, Martin Lukáš, Veronika Hrubá, Naděžda Machková, Karin Malíčková, Milan LukášEfficacy of ustekinumab in a patient refractory to other biological treatment
Case reportGastroent Hepatol 2018; 72(1): 47–49. doi:10.14735/amgh201847
SummaryLiteraturepdf Martin Bortlík, Naděžda Machková, Veronika Hrubá, Martin Lukáš, Dana Ďuricová, Karin Malíčková, Zuzana Šerclová, Milan LukášImpact of anti-TNFα exposure in utero on the development of immune systems of exposed children – a controlled, multicentre observational study
Original articleGastroent Hepatol 2018; 72(6): 479–485. doi:10.14735/amgh2018479
SummaryLiteraturepdf Dana Ďuricová, Eva Dvořáková, Ondřej Hradský, Katarína Mitrová, Marianna Durilová, Jana Koželuhová, Pavel Kohout, Kristýna Zárubová, Jiří Bronský, Nora Hradská, Eva Bronská, Miroslava Adamcová, Naděžda Machková, Veronika Hrubá, Martin Bortlík, Martin Lukáš, Karin Malíčková, Milan Lukáš